Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2025-12-25 @ 2:25 PM
NCT ID:
NCT02502266
Group ID:
EG005
Title:
Arm VI: (Arm II Regimen: JP Patients Enrolled After P3 Cutoff)
Description:
Patients receive cediranib maleate orally (PO) once daily (QD) and olaparib PO twice daily (BID). Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. Patients also undergo CT and MRI throughout the study. Patients enrolled from Japan after the Phase III cutoff.
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
0
Serious Number At Risk:
7
Other Number Affected:
7
Other Number At Risk:
7
Study:
NCT02502266
Results Section:
NCT02502266
Adverse Events Module:
NCT02502266